Document Detail

Trypsinogen and other pancreatic enzymes in patients with renal disease: a comparison of high-efficiency hemodialysis and continuous ambulatory peritoneal dialysis.
MedLine Citation:
PMID:  7540759     Owner:  NLM     Status:  MEDLINE    
Although serum amylase and lipase levels have been studied extensively in patients with renal disease, there are fewer data regarding trypsinogen levels in patients with end-stage renal disease (ESRD) treated with different dialytic modalities. We therefore evaluated the blood concentrations of trypsinogen, amylase, and lipase in asymptomatic patients with chronic renal insufficiency (CRI) and ESRD, to determine whether treatment modality or renal handling of these enzymes is important in determining steady-state levels in asymptomatic patients with chronic renal disease. Mean trypsinogen concentration levels were higher in hemodialysis (HD) patients and patients with CRI compared with normal subjects when values in the different groups were compared. There was no difference in the mean trypsinogen levels between patients treated with HD and those with CRI, between patients treated with chronic ambulatory peritoneal dialysis (CAPD) and those treated with HD, or between CAPD patients and patients with CRI. The mean circulating trypsinogen concentration was elevated more frequently and to a higher level than amylase or lipase in patients with CRI and ESRD. HD treatment did not result in a lowering of mean circulating pancreatic enzyme levels. We propose that decreased peripheral clearance, pancreatic overproduction, increased release from the pancreas, or a combination of these mechanisms is responsible, at least in part, for the increased plasma concentration of trypsinogen in patients with CRI, rather than simply a decrease in renal clearance.
P L Kimmel; S Tenner; V Q Habwe; J Henry; S Lakshminarayan; W Steinberg
Related Documents :
8255479 - Evidence for impairment of energy metabolism in vivo in huntington's disease using loca...
20938099 - Characteristics of revascularization treatment for arteriosclerosis obliterans in patie...
8445839 - Dialysis therapy in the elderly patient.
20309409 - Effect of educational level on oral health in peritoneal and hemodialysis patients.
20692969 - Inhibitory effect of cysteine and methionine on free radicals induced by mercury in red...
8676799 - Folic acid treatment of hyperhomocysteinemia in dialysis patients.
6161729 - Antiarrhythmic effect of the calcium antagonist tiapamil (ro 11-1781) by intravenous ad...
8644819 - Microsporidial keratoconjunctivitis caused by septata intestinalis in a patient with ac...
17456869 - Determining contrast medium dose and rate on basis of lean body weight: does this strat...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Pancreas     Volume:  10     ISSN:  0885-3177     ISO Abbreviation:  Pancreas     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-07-27     Completed Date:  1995-07-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8608542     Medline TA:  Pancreas     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  325-30     Citation Subset:  IM    
Department of Medicine, George Washington University Medical Center, Washington, DC, 20037 USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amylases / blood
Kidney Failure, Chronic / enzymology*,  therapy
Lipase / blood
Middle Aged
Pancreas / enzymology*
Peritoneal Dialysis, Continuous Ambulatory*
Renal Dialysis*
Trypsinogen / blood*
Reg. No./Substance:
9002-08-8/Trypsinogen; EC; EC 3.2.1.-/Amylases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Trophoblast basement membrane haemosiderosis in the placental lesion of fetal artery thrombosis: a m...
Next Document:  The relationship between pancreatic enzyme release and activation and the acute-phase protein respon...